0001076167-11-000033.txt : 20111209 0001076167-11-000033.hdr.sgml : 20111209 20111209140536 ACCESSION NUMBER: 0001076167-11-000033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111207 FILED AS OF DATE: 20111209 DATE AS OF CHANGE: 20111209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADOLOR CORP CENTRAL INDEX KEY: 0001076167 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 311429198 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 PENNSYLVANIA DRIVE CITY: EXTON STATE: PA ZIP: 19341 MAIL ADDRESS: STREET 1: 700 PENNSYLVANIA DRIVE CITY: EXTON STATE: PA ZIP: 19341 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Magni Guido CENTRAL INDEX KEY: 0001437150 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30039 FILM NUMBER: 111253016 MAIL ADDRESS: STREET 1: 700 PENNSYLVANIA DRIVE CITY: EXTON STATE: PA ZIP: 19341 4 1 primary_doc.xml PRIMARY DOCUMENT X0304 4 2011-12-07 0 0001076167 ADOLOR CORP ADLR 0001437150 Magni Guido 700 PENNSYLVANIA DRIVE EXTON PA 19341 1 0 0 0 Adolor Common Stock (ADLR) 2011-12-07 4 M 0 30000 1.77 A 35141 D Adolor Common Stock (ADLR) 2011-12-07 4 M 0 20000 2.2 A 55141 D Adolor Common Stock (ADLR) 2011-12-07 4 M 0 20000 1.6 A 75141 D Adolor Common Stock (ADLR) 2011-12-07 4 M 0 30000 1.39 A 105141 D Adolor Common Stock (ADLR) 2011-12-07 4 M 0 30000 1.5 A 135141 D Adolor Common Stock (ADLR) 2011-12-07 4 U 0 135141 D 0 D Stock Option (right to buy) 1.77 2011-12-07 4 M 0 30000 0 D Adolor Common Stock (ADLR) 30000 0 D Stock Option (right to buy) 2.2 2011-12-07 4 M 0 20000 0 D Adolor Common Stock (ADLR) 20000 0 D Stock Option (right to buy) 1.6 2011-12-07 4 M 0 20000 0 D Adolor Common Stock (ADLR) 20000 0 D Stock Option (right to buy) 1.39 2011-12-07 4 M 0 30000 0 D Adolor Common Stock (ADLR) 30000 0 D Stock Option (right to buy) 1.5 2011-12-07 4 M 0 30000 0 D Adolor Common Stock (ADLR) 30000 0 D Shares are tendered pursuant to the tender offer commenced with respect to the Issuer's shares (the "Offer") at a purchase price of $4.25 per share in cash, plus one non-transferable contingent payment right for each share, which shall represent the right to receive up to $4.50 in cash subject to the fulfillment of certain conditions and/or the attainment of certain milestones, upon the terms and subject to the conditions set forth in the Offer. Transaction pertains to the vesting of unvested stock options and the issuance of shares of common stock underlying certain vested stock options, pursuant to the terms of the Agreement and Plan of Merger, dated as of October 24, 2011, by and among the Issuer, FRD Acquisition Corporation and Cubist Pharmaceuticals, Inc. and the related Offer. /s/ John M. Limongelli, Attorney-in-fact for Guido Magni 2011-12-09